Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes
Clinical trial NCT01581658 · COMPLETED
Trial details
- NCT number
- NCT01581658
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2012-11-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.